Optimizing benefit-risk and minimizing impact on quality of life with BCMA-targeting agents in an outpatient setting

Speaker(s)

• 

  Meletios A. Dimopoulos, MD

  Professor and Chairman of the Department of Clinical Therapeutics
  National and Kapodistrian University of Athens, Greece